From roadmap to a sustainable end-to-end individualized therapy pathway
{{output}}
The field of individualized, or N-of-1, therapy development is growing and increasingly gaining attention as a novel option for people with serious diseases, caused by unique genetic variants for whom approved therapies are not available. The N-of-1 taskforce ... ...
